首页> 外文期刊>Journal of clinical apheresis. >Successful Hematopoietic Stem Cell Collection in Patients Who Fail Initial Plerixafor Mobilization for Autologous Stem Cell Transplant
【24h】

Successful Hematopoietic Stem Cell Collection in Patients Who Fail Initial Plerixafor Mobilization for Autologous Stem Cell Transplant

机译:未能成功动员最初的Plerixa进行自体干细胞移植动员的患者成功造血干细胞收集

获取原文
获取原文并翻译 | 示例
           

摘要

We report our experience of collecting stem cells in patients who failed to mobilize sufficient hematopoietic stem cell (HSC) using plerixafor (P) in the initial mobilization attempt. Twenty four patients were identified who failed a first mobilization attempt using P. Of these, 22 patients received granulocyte colony stimulating factor (G-CSF) and two patients received cyclophosphamide (CY)+G-CSF in combination with P for the initial attempt. The agents used for second collection attempt were granulocyte macrophage colony stimulating factor (GM-CSF)+G-CSF (19 patients), G-CSF+P (three patients), CY+G-CSF (one patient), and bone marrow harvest (one patient). A median of 0.6 x 10(6) CD34(+) cells/kg (range 0-1.97) were collected in the initial attempt. A second collection was attempted at a median of 22 days (range 15-127) after the first failed mobilization. The median CD34(+) cell dose collected with the second attempt was 1.1 x 10(6) CD34(+) cells/kg (range 0-7.2). A third collection was attempted in six patients at median of 51 days (range 34-163) after the first failed mobilization. These patients collected a median of 1.1 x 10(6) CD34(+) cells/kg (range 0-6.5). Total of 16 patients (67%) collected sufficient cells to undergo autologous stem cell transplant and eight patients (33%) were able to collect 2 x 10(6) CD34(+) cells/kg in a single subsequent attempt. Our experience suggests that a majority of patients who fail primary mobilization despite use of P can collect sufficient HSC with a subsequent attempt using combination of G-CSF with either P or GM-CSF. J. Clin. Apheresis 29:293-298 2014. (c) 2014 Wiley Periodicals, Inc.
机译:我们报告了在最初的动员尝试中未能使用plerixafor(P)动员足够的造血干细胞(HSC)的患者中收集干细胞的经验。鉴定出24例首次使用P动员失败的患者。其中22例接受粒细胞集落刺激因子(G-CSF),两名患者与P联合使用环磷酰胺(CY)+ G-CSF。用于第二次收集尝试的药物是粒细胞巨噬细胞集落刺激因子(GM-CSF)+ G-CSF(19例),G-CSF + P(3例),CY + G-CSF(1例)和骨髓收获(一名患者)。在最初的尝试中,收集到的中位数为0.6 x 10(6)CD34(+)细胞/ kg(范围0-1.97)。在第一次动员失败后的中位数22天(范围15-127),尝试进行第二次收集。第二次尝试收集的平均CD34(+)细胞剂量为1.1 x 10(6)CD34(+)细胞/ kg(范围为0-7.2)。首次动员失败后,对六名患者进行了中位51天(范围34-163)的第三次采集。这些患者收集的中位数为1.1 x 10(6)CD34(+)细胞/ kg(范围0-6.5)。共有16位患者(67%)收集到足以进行自体干细胞移植的细胞,八位患者(33%)能够在一次后续尝试中收集2 x 10(6)CD34(+)细胞/ kg。我们的经验表明,尽管使用P但仍未能进行主要动员的大多数患者可以收集足够的HSC,随后尝试将G-CSF与P或GM-CSF联合使用。 J.临床。 Apheresis 29:293-2982014。(c)2014 Wiley Periodicals,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号